186 related articles for article (PubMed ID: 23555892)
21. Functional variant of MTOR rs2536 and survival of Chinese gastric cancer patients.
Cheng L; Qiu L; Zhang R; Qian D; Wang M; Sun M; Zhu X; Wang Y; Guo W; Wei Q
Int J Cancer; 2019 Jan; 144(2):251-262. PubMed ID: 29978580
[TBL] [Abstract][Full Text] [Related]
22. A Functional Polymorphism (rs2494752) in the AKT1 Promoter Region and Gastric Adenocarcinoma Risk in an Eastern Chinese Population.
Wang MY; He J; Zhu ML; Teng XY; Li QX; Sun MH; Wang XF; Yang YJ; Wang JC; Jin L; Wang YN; Wei QY
Sci Rep; 2016 Jan; 6():20008. PubMed ID: 26818920
[TBL] [Abstract][Full Text] [Related]
23. DNMT3A rs36012910 A>G polymorphism and gastric cancer susceptibility in a Chinese population.
Wu Q; Lu S; Wang L; Hu J; Qiao F; Qiu X; Zhao C; Lao Y; Song Y; Fan H
Mol Biol Rep; 2012 Dec; 39(12):10949-55. PubMed ID: 23053986
[TBL] [Abstract][Full Text] [Related]
24. Association of genetic variations in mTOR with risk of childhood acute lymphoblastic leukemia in a Chinese population.
Huang L; Huang J; Wu P; Li Q; Rong L; Xue Y; Lu Q; Li J; Tong N; Wang M; Zhang Z; Fang Y
Leuk Lymphoma; 2012 May; 53(5):947-51. PubMed ID: 21973240
[TBL] [Abstract][Full Text] [Related]
25. A functional polymorphism in the DNA methyltransferase-3A promoter modifies the susceptibility in gastric cancer but not in esophageal carcinoma.
Fan H; Liu D; Qiu X; Qiao F; Wu Q; Su X; Zhang F; Song Y; Zhao Z; Xie W
BMC Med; 2010 Feb; 8():12. PubMed ID: 20128888
[TBL] [Abstract][Full Text] [Related]
26. DNMT3B promoter polymorphism and risk of gastric cancer.
Hu J; Fan H; Liu D; Zhang S; Zhang F; Xu H
Dig Dis Sci; 2010 Apr; 55(4):1011-6. PubMed ID: 19517237
[TBL] [Abstract][Full Text] [Related]
27. MTOR gene polymorphism may be associated with microscopic polyangiitis susceptibility in a Guangxi population of China.
Lan J; Zhu Y; Rao J; Liu L; Gong A; Feng F; Chen B; Huang J; Zhang Y; Chu L; Zhong H; Li L; Yan J; Li W; Xue C
Gene; 2023 Feb; 854():147101. PubMed ID: 36496178
[TBL] [Abstract][Full Text] [Related]
28. The association analysis of hOGG1 genetic variants and gastric cancer risk in a Chinese population.
Lu J; Yin Y; Du M; Ma G; Ge Y; Zhang Q; Chu H; Tong N; Wang M; Qiu J; Zhang Z
Oncotarget; 2016 Oct; 7(40):66061-66068. PubMed ID: 27603140
[TBL] [Abstract][Full Text] [Related]
29. Study on the association between PI3K/AKT/mTOR signaling pathway gene polymorphism and susceptibility to gastric cancer.
Qi L; Sun K; Zhuang Y; Yang J; Chen J
J BUON; 2017; 22(6):1488-1493. PubMed ID: 29332342
[TBL] [Abstract][Full Text] [Related]
30. Role of TNF-α -308G/A gene polymorphism in gastric cancer risk: A case control study and meta-analysis.
Du LC; Gao R
Turk J Gastroenterol; 2017 Jul; 28(4):272-282. PubMed ID: 28699601
[TBL] [Abstract][Full Text] [Related]
31. Association of genetic variants in lncRNA GAS5/miR-21/mTOR axis with risk and prognosis of coronary artery disease among a Chinese population.
Li H; Liu Y; Huang J; Liu Y; Zhu Y
J Clin Lab Anal; 2020 Oct; 34(10):e23430. PubMed ID: 32557866
[TBL] [Abstract][Full Text] [Related]
32. Functional promoter -308G>A variant in tumor necrosis factor α gene is associated with risk and progression of gastric cancer in a Chinese population.
Hong Y; Ge Z; Jing C; Shi J; Dong X; Zhou F; Wang M; Zhang Z; Gong W
PLoS One; 2013; 8(1):e50856. PubMed ID: 23326309
[TBL] [Abstract][Full Text] [Related]
33. Identification of a synonymous variant in TRIM59 gene for gastric cancer risk in a Chinese population.
Luo D; Wang Y; Huan X; Huang C; Yang C; Fan H; Xu Z; Yang L
Oncotarget; 2017 Feb; 8(7):11507-11516. PubMed ID: 28009992
[TBL] [Abstract][Full Text] [Related]
34. Effects of the mTOR and AKT genes polymorphisms on systemic lupus erythematosus risk.
Saravani M; Shahraki-Ghadimi H; Maruei-Milan R; Mehrabani M; Mirzamohammadi S; Nematollahi MH
Mol Biol Rep; 2020 May; 47(5):3551-3556. PubMed ID: 32319007
[TBL] [Abstract][Full Text] [Related]
35. The DNA repair gene ERCC6 rs1917799 polymorphism is associated with gastric cancer risk in Chinese.
Liu JW; He CY; Sun LP; Xu Q; Xing CZ; Yuan Y
Asian Pac J Cancer Prev; 2013; 14(10):6103-8. PubMed ID: 24289633
[TBL] [Abstract][Full Text] [Related]
36. The possible effects of the MTOR polymorphisms on preeclampsia susceptibility, severity, and onset: a case-control study and in silico analysis.
Rezaei M; Ghasemi M; Saravani M; Ghahghayi F; Shahraki-Ghadim H; Salimi S
Mol Biol Rep; 2024 Feb; 51(1):335. PubMed ID: 38393518
[TBL] [Abstract][Full Text] [Related]
37. Effects of the MTOR and AKT1 genes polymorphisms on papillary thyroid cancer development.
Maruei-Milan R; Saravani M; Heidari Z; Asadi-Tarani M; Salimi S
IUBMB Life; 2020 Dec; 72(12):2601-2610. PubMed ID: 33107190
[TBL] [Abstract][Full Text] [Related]
38. Breast Cancer Risk-Associated SNPs in the
Chen Q; Deng X; Hu X; Guan S; He M; Wang Y; Wei B; Zhang J; Zhao H; Yao W; Jin F; Liu Y; Chen J; Olapade OI; Wu H; Wei M
Mol Cancer Res; 2019 Nov; 17(11):2244-2256. PubMed ID: 31467112
[TBL] [Abstract][Full Text] [Related]
39. The associations of hub gene polymorphisms in PI3K/AKT/mTOR pathway and Schistosomiasis Japonica infection and hepatic fibrosis.
Xiao Q; Yu H; Zhu X
Infect Genet Evol; 2020 Nov; 85():104423. PubMed ID: 32554084
[TBL] [Abstract][Full Text] [Related]
40. The functional variant in promoter of OVCA1 was associated with the risk of gastric cancer in the northeast Chinese Han population.
Yu L; Li Y; Wang H; Wang D; Hao H; Zhang D; Liang X; Cai M; Guan R; Bai J; Yu J
Pathol Res Pract; 2022 Feb; 230():153755. PubMed ID: 34990869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
